Omada Health

What Omada Health does

Omada Health is a US-based digital behavioral medicine company founded in 2011 that delivers virtual care programs for chronic cardiometabolic and musculoskeletal conditions. The platform combines human coaching (CDCES-certified clinicians, cardiometabolic specialists, physical activity specialists) with connected smart devices (smart scales, blood pressure monitors, and continuous glucose meters including Abbott FreeStyle Libre), a mobile app, peer communities, and AI-driven behavioral support — including Generative AI / Conversational AI features and an AI-powered nutrition scanner trained for members on GLP-1 medications. Programs cover prediabetes and weight health, type 2 diabetes, hypertension, cholesterol (launched February 2026), GLP-1 support and prescribing (50-state rollout announced November 2025), and musculoskeletal care (delivered in partnership with Physera Physical Therapy Group, P.C.).

The company operates a B2B2C model, selling primarily to enterprise buyers — employers, health plans, benefit consultants, and health systems — through direct enterprise sales and via distribution partners that include all three of the largest U.S. pharmacy benefit managers (Optum Rx Weight Engage, Express Scripts, and Caremark) plus Eli Lilly's Employer Connect program. Members access programs at no cost when sponsored by their employer or health plan. As of Q1 2026, 1,900+ organizations were enrolled, total membership reached 1.02 million, and more than 2 million members have been served since launch; over 150,000 members were on GLP-1 medications at the end of 2025. Reported customer outcomes include 67% one-year GLP-1 persistence (vs 47–49% benchmark), 18.4% average weight loss, and 90%+ three-year customer retention.

Omada Health completed its initial public offering on Nasdaq (ticker OMDA) on June 6, 2025, raising approximately $150 million. FY2025 revenue was $260.21 million (53% YoY growth), Q1 2026 revenue was $78 million (42% YoY), and full-year 2026 guidance is $324–332 million. The company achieved its first GAAP-profitable quarter in Q4 2025 ($5.16M net income) and reported a $212M cash position with zero debt as of May 2026. The PREVENT DIABETES Act, signed in February 2025, permanently authorized virtual-only providers such as Omada to participate in the Medicare Diabetes Prevention Program through 2030, opening a federally reimbursed channel for the company's flagship Prevention & Weight Health program.

Name

Omada Health

Legal name

Omada Health, Inc.

Website

https://omadahealth.com

Company type

Public

Founded year

2011

Operating status

Ipo

Headcount range

501–1,000 employees

Short description

Omada Health is a public (Nasdaq: OMDA) digital health company that delivers virtual cardiometabolic and musculoskeletal care programs to over 1 million members via employer and health plan sponsors, combining human coaching, connected devices, and AI-powered support.

Ownership category

akta.pro rank

Product category

Virtual Chronic Care

NAICS

Health and Welfare Funds (525120), Services for the Elderly and Persons with Disabilities (624120)

SIC

Hospital & Medical Service Plans (6324), Services-Misc Health & Allied Services, Nec (8090), Services-Prepackaged Software (7372)

akta.pro primary industry

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)

akta.pro secondary industries

Care Navigation, Advocacy & Benefits Guidance Platforms (HLALADAJ), HIE Platforms & Network Services (Community/Regional/National) (HLACABAB), Chronic Condition Virtual Care & Disease Management (Payer-Sponsored) (HLALACAE), Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• Virtual chronic care
• Digital therapeutics
• Cardiometabolic care platform
• GLP-1 companion program
• Musculoskeletal virtual care

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure

Revenue model

1. Enterprise B2B Contracts with Employers and Health Plans: Recurring/contract-based revenue from employers, health plans, benefit consultants, and health systems who purchase the Omada virtual care programs (Prevention/Weight Health, Diabetes, Hypertension, MSK, Cholesterol, GLP-1 Care Track, GLP-1 Prescribing) for their covered populations; 1,900+ organizations enrolled and over 1,700 customers reported as of 2022.
2. Pharmacy & PBM Channel Revenue (GLP-1 Adjacent): Revenue from partnerships with the three largest U.S. PBMs (Optum Rx Weight Engage, plus Express Scripts and Caremark relationships) and Eli Lilly's Employer Connect program, which channel prescribing and clinical support services for GLP-1 anti-obesity medications.
3. Self-Pay / GLP-1 Flex Care Program: New employer-facing GLP-1 Flex Care program (launching later 2026) where employers pay for clinical evaluation, prescribing and ongoing virtual care, while employees purchase GLP-1 medications independently through cash-pay channels, allowing employers to offer structured GLP-1 care without taking on open-ended medication costs.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Core offering

Omada Health operates a virtual chronic-care platform that delivers condition-specific programs (Prevention & Weight Health, Diabetes, Hypertension, Cholesterol, GLP-1 Care Track, GLP-1 Prescribing, and Joint & Muscle Health) to members of employer-sponsored and health-plan-sponsored benefits. Programs combine personalized human coaching (CDCES, cardiometabolic specialists, physical activity specialists, physical therapists) with connected smart devices shipped to members' homes, a mobile app, peer community, and proprietary Generative AI / Conversational AI support. The company now serves 1,900+ organizations and 1M+ members across all 50 US states.

Differentiator

Problem solved

Functional benefit

Brands

• Omada for Prevention & Weight Health: Virtual care program for prediabetes, weight management, and chronic disease prevention
• Omada for Diabetes
• Omada for Hypertension
• Omada for Cholesterol
• Omada for Joint & Muscle Health
• Omada GLP-1 Care Track / Enhanced GLP-1 Care Track
• Omada GLP-1 Flex Care

Products and services

• Omada for Prevention & Weight Health Virtual care program for prediabetes and weight management, providing personalized one-on-one coaching, smart connected devices (smart scale, blood pressure monitor), peer community, and behavior change support to help members lose weight, build sustainable habits, and reduce cardiometabolic risk. Offered to eligible members at no cost when covered by an employer or health plan; eligible to participate in the Medicare Diabetes Prevention Program (MDPP) under the PREVENT DIABETES Act through 2030.
• Omada for Diabetes Virtual diabetes management program that pairs members with a dedicated health coach and a CDCES-certified clinical specialist, provides a connected welcome kit including a FreeStyle Libre 3 Plus continuous glucose monitor (CGM) for eligible members, and uses AI-supported coaching to drive A1C reduction, blood glucose control, and medication adherence. CGMs are not available to Medicare, Medicaid, or other government payers at no cost.
• Omada for Hypertension Virtual blood pressure management program that pairs members with a dedicated health coach and a hypertension specialist, ships a connected blood pressure monitor welcome kit, and applies AI-supported coaching to drive behavior change and medication adherence for blood pressure control. 96% hypertension program satisfaction cited on the Omada website.
• Omada for Cholesterol Virtual cholesterol management program that uses human-led coaching amplified by AI to deliver behavior change support and medication adherence guidance, with a focus on early lifestyle modifications to prevent serious cardiovascular events. Launched in February 2026 with a market-leading employer customer.
• Omada GLP-1 Care Track / Enhanced GLP-1 Care Track Wraparound virtual care program for members on GLP-1 anti-obesity medications that pairs a health coach, cardiometabolic specialist, and physical activity specialist with AI-supported nutrition guidance (including an AI scanner for food/menu support). Reported clinical outcomes include 67% medication persistence at one year versus a 47-49% benchmark and 18.4% average weight loss versus an 11.9% real-world benchmark.
• Omada GLP-1 Prescribing Capability Anti-obesity medication (AOM) prescribing service, including GLP-1s, that supports members throughout the medication journey with clinical eligibility, behavioral support, and medication management. Targets improved weight and cardiometabolic outcomes and is being rolled out across all 50 US states starting in the first half of 2026.
• Omada GLP-1 Flex Care Employer-sponsored virtual care program providing clinical evaluation, prescribing, and ongoing virtual care for GLP-1 obesity medications while enabling employees to purchase medications independently through cash-pay channels. Designed to help employers offer structured GLP-1 care without taking on open-ended medication costs; announced for rollout to employers later in 2026.
• Omada for Joint & Muscle Health (MSK) Digital musculoskeletal (MSK) care program providing virtual physical therapy — including video visits, exercise videos, and treatment plans — delivered through a web-based application used by licensed physical therapists in partnership with Physera Physical Therapy Group, P.C. Members not experiencing a relevant MSK condition may instead receive a preventive version (different features; does not include a physical therapist). Subject to health-plan deductibles, copays, and co-insurance. 80% of members finish treatment plans; 99% are highly satisfied with quality of care.

Quantifiable outcome

• First-year per-member savings of $1,000+; 90%+ three-year customer retention
• +8 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature7 records

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• Digital Medicine Society (DiMe)coreStrategic or Co-development Partner · 9 June 2026DiMe launched the Post-Contracting Operational Readiness for Virtual-First Care initiative with Omada Health as title sponsor. The 3.5-month sprint builds a toolkit for integrating contracted virtual care providers within 90 days of contract signature, aligned with 2026 No Surprises Act provider-directory accuracy requirements and CMS Final Rule.
• Eli Lilly (Employer Connect program)flagshipGTM or Marketing Partner · 7 May 2026Omada Health joined Eli Lilly's Employer Connect program as a digital coaching and prescribing partner, enabling direct-to-employer access to GLP-1 medications through Omada's prescribing capabilities and behavioral coaching. The partnership was announced alongside Q1 2026 earnings.
• Optum Rx (Weight Engage program)flagshipChannel Partner/ Reseller/ Distributor · 1 May 2026Omada Health signed a partnership with Optum Rx to provide its Weight Engage program as part of Optum Rx's GLP-1 management offerings, giving employers and patients clinically supervised prescribing and wraparound support for GLP-1 weight-loss drugs. Through this deal, Omada gained relationships with all three of the largest U.S. PBMs.
• NCQA (Measuring Patient Engagement Learning Collaborative)minorStrategic or Co-development Partner · 10 February 2026NCQA's inaugural Measuring Patient Engagement Learning Collaborative, launched Feb 10, 2026 in Washington D.C., convenes 13 organizations (health plans, vendors, clinicians, policymakers) including Omada; the initiative is funded in part by the Helmsley Charitable Trust.
• Abbott (FreeStyle Libre)coreTechnology or Integration · 20 November 2025Abbott announced a partnership with Omada Health to provide FreeStyle Libre users access to Omada's digital coaching platform for lifestyle management support. Abbott and Omada also have planned data-sharing integrations via the FreeStyle Libre continuous glucose monitor.
• Apple HealthKit and Google (third-party data sources)coreTechnology or Integration · 20 November 2025Omada supports data ingestion from Apple HealthKit, Google health services, and other third-party health devices; Abbott also announced planned integrations between FreeStyle Libre and partners including Novo Nordisk, Sanofi, Tandem, and Bigfoot for broader data-sharing across diabetes and cardiovascular care.
• Unnamed health insurer (strategic partnership)coreChannel Partner/ Reseller/ Distributor · 1 September 2025Market research notes Omada Health entered a strategic partnership with a health insurer in September 2025 as part of broader digital therapeutics market developments.
• Amazon HealthcoreGTM or Marketing Partner · 1 January 2024Amazon partnered with Omada Health in January 2024 to launch a chronic condition management program integrating real-time health tracking and virtual coaching for patients with diabetes, hypertension, and heart disease.
• Physera Physical Therapy Group, P.C.coreOEM/ Whitelabel/ Licensing PartnerOmada Health works in partnership with Physera Physical Therapy Group, PC and other contracted partners to deliver the Omada for Joint & Muscle Health Program; licensed physical therapists who are employees or contractors of Physera provide virtual physical therapy services through a dedicated web-based application.
• Cigna (two Cigna-affiliated entities)flagshipChannel Partner/ Reseller/ DistributorTwo Cigna-affiliated entities together represent approximately 66% of Omada Health's revenue, per analyst coverage; flagged as a key customer-concentration risk.

Scale indicators16 records

Recent moves7 records

Expansion highlights7 records

Broad incumbents

• Teladoc Health: Public telehealth incumbent that acquired Livongo, the closest analog to Omada's chronic-condition platform. Operates across telehealth, chronic care (Livongo for diabetes, hypertension, weight), mental health (BetterHelp), and integrated virtual care—overlapping directly with Omada's cardiometabolic and GLP-1 management offerings at much larger scale.
• Ro: Direct-to-patient telehealth and pharmacy company operating across weight management (Ro Body), mental health, and chronic conditions. Competes with Omada for cardiometabolic and GLP-1 patients, with a stronger consumer and pharmacy fulfillment layer.

Direct peers

• Hinge Health: Digital musculoskeletal care platform that co-IPO'd with Omada in 2025 and is widely cited alongside Omada as a bellwether digital health exit. Both target employer and health plan buyers with virtual care programs for chronic conditions, using connected devices, coaching, and AI.
• Virta Health: Virtual care company specializing in type 2 diabetes reversal and metabolic disease management. Sells to employers and health plans with a coaching + remote-monitoring model that directly competes with Omada for Diabetes and Prevention/Weight Health. Also named alongside Omada as a PBM-channel partner for GLP-1 management.
• Noom: Consumer- and employer-facing weight management and behavior change platform. Competes with Omada in the cardiometabolic and weight health category, with a stronger consumer brand and psychology-led approach.
• DarioHealth: Digital chronic-condition management platform spanning diabetes, hypertension, musculoskeletal, and behavioral health. Sells to employers and payers with a similar B2B2C virtual care model and is named alongside Omada as a CMS-recognized virtual DPP provider.
• Sword Health: Digital musculoskeletal care platform combining virtual physical therapy with AI. Competes head-to-head with Omada for Joint & Muscle Health for employer and health plan contracts.
• WellDoc: Digital therapeutics company focused on diabetes management with BlueStar, an FDA-cleared mobile diabetes platform. Direct competitor in diabetes management apps and virtual chronic care for self-insured employers and payers.
• Calibrate: GLP-1-focused virtual weight management program combining metabolic reset coaching with clinician-supervised medication use. Competes directly with Omada's GLP-1 Care Track and GLP-1 Flex Care for employer and consumer dollars.
• Kaia Health: Digital MSK and chronic pain management platform with employer and payer distribution. Listed alongside Omada as a key player in the MSK disease management market; competes in the same benefit category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/omadahealth
• YouTubeyoutube.com/@omadahealth
• Facebookfacebook.com/omadahealth
• LinkedInlinkedin.com/company/omada-health
• Instagraminstagram.com/omadahealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds13 records

Investors36 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Omada Health